NET PROFIT (x1000 EUR)
EMPLOYEES
Biomedrex AB
Closing information (x1000 EUR)
| Closing information | 2023/06 | 2022/06 | 2021/06 |
| Turnover |
0
|
0
|
0 |
| Financial expenses |
17
|
19
|
4 |
| Earnings before taxes |
33
|
-78
|
-39 |
| EBITDA |
49
|
-58
|
-34 |
| Total assets |
1,354
|
1,394
|
667 |
| Current assets |
17
|
100
|
82 |
| Current liabilities |
319
|
296
|
98 |
| Equity capital |
399
|
386
|
420 |
| - share capital |
4
|
5
|
5 |
| Employees (average) |
3
|
8
|
4 |
Financial ratios
| Fiscal year | 2023/06 | 2022/06 | 2021/06 |
| Solvency |
29.5%
|
27.7%
|
63.0% |
| Turnover per employee |
0
|
0
|
0 |
| Profit as a percentage of turnover | |||
| Return on assets (ROA) |
3.7%
|
-4.2%
|
-5.2% |
| Current ratio |
5.3%
|
33.8%
|
83.7% |
| Return on equity (ROE) |
8.3%
|
-20.2%
|
-9.3% |
| Change turnover |
0
|
0
|
-51 |
| Change turnover % | -100% | ||
| Chg. No. of employees |
-5
|
4
|
3 |
| Chg. No. of employees % |
-63%
|
100%
|
300% |
Total value of public sale
| Fiscal year | 2023/06 | 2022/06 | 2021/06 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.